Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: Preliminary 31P-MRS and CT studies

European Archives of Psychiatry and Clinical Neuroscience

Volumn 250, Issue 4, 2000, Pages 169-174

  Shioiri, Toshiki ^a   Hamakawa, Hiroshi ^b   Kato, Tadafumi ^c   Fujii, Kumiko ^b   Murashita, Jun ^b   Inubushi, Toshiro ^b   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Frontal lobe; Phosphodiester (PDE); Phosphomonoester (PME); Phosphorous 31 magnetic resonance spectroscopy (31P MRS); Ventricle to brain ratio (VBR)

Indexed keywords

ORGANOPHOSPHATE; PHOSPHOLIPID;

ADOLESCENT; ADULT; ARTICLE; BRAIN VENTRICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FRONTAL LOBE; HUMAN; MALE; PHOSPHOLIPID MEMBRANE; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0033838795     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004060070021     Document Type: Article

References (42)

1. Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms
2. 13C NMR
3. Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter
4. Resolution enhancement of protein PMR spectra using the difference between a broadened and a normal spectrum
5. Lack of bimodal distribution of ventricular size in schizophrenia
6. Enzymatic pathways of phospholipid metabolism in the nervous system
7. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia
8. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
9. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging
10. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients
11. Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients
12. The Practitioner Guide to Psychoactive Drugs
13. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia
14. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder
15. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia
16. Phosphorus-31 magnetic resonance spectroscopic observations in 4 cases with anorexia nervosa
17. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies
18. Spin-spin relaxation of the phosphodiester resonance in the 31P NMR spectrum of human brain: The determination of the concentrations of phosphodiester components
19. Cortical gray matter volume deficits in patients with first-episode schizophrenia
20. Gray matter volume deficits in young onset schizophrenia are independent of age of onset
21. MRI anatomy of schizophrenia
22. Magnetic resonance imaging in schizophrenia: Relationship with clinical measures
23. Progression of cerebroventricular enlargement and the subtyping of schizophrenia
24. Ventricularbrain ratio, computed tomographic density and brain area in 50 schizophrenics
25. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics
26. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls
27. Diffuse brain abnormality in schizophrenia
28. Decreased phosphorus metabolite concentrations and alkalosis in chronic cerebral infarction
29. Decreased regional cortical gray matter volume in schizophrenia
30. 31P-MRS-measured phosphomonoester in the frontal region and negative symptoms in schizophrenia
31. 31P-MRS
32. Multiple regression analysis of relationship between the frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia
33. 31P-MR spectroscopy study
34. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders
35. 31P-magneto-resonance spectroscopic study
36. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics: A study including 50 patients and 36 controls
37. Increase of phosphodiesters during neuroleptic treatment of schizophrenics: A longitudinal 31P-magnetic resonance spectroscopic study
38. Localized phosphorous-31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls
39. Brain morphology assessed by computed tomography in patients with geriatric depression, patients with degenerative dementia, and normal control subjects
40. Widespread cerebral gray matter volume deficits in schizophrenia